or Try an Advanced Search...

    Technical Analysis for SAVA - Cassava Sciences, Inc.

    Grade Last Price % Change Price Change
    D 22.03 -1.87% -0.42
    SAVA closed down 1.87 percent on Friday, May 31, 2024, on 72 percent of normal volume. It was able to find support at its 50 day moving average.
    5 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Up Flat
    Historical SAVA trend table...
    Date Alert Name Type % Chg
    20 DMA Support Bullish 0.00%
    50 DMA Support Bullish 0.00%
    Bollinger Band Squeeze Range Contraction 0.00%
    Crossed Above 20 DMA Bullish -1.87%
    Crossed Above 200 DMA Bullish -1.87%
    Crossed Above 50 DMA Bullish -1.87%
    180 Bullish Setup Bullish Swing Setup -1.87%
    Bollinger Band Squeeze Range Contraction -1.87%
    Fell Below 200 DMA Bearish 3.52%
    Fell Below 50 DMA Bearish 3.52%
    Older End-of-Day Signals for SAVA ...

       Recent Intraday Alerts

    Alert Time
    50 DMA Support 1 day ago
    Down 3% 1 day ago
    Fell Below 20 DMA 1 day ago
    20 DMA Support 1 day ago
    10 DMA Support 1 day ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    SAVA Chart by TradingView
    Basic chart:

    Profile

    Cassava Sciences, Inc. develops drugs for nervous system disorders in the United States. It engages in developing FENROCK, a proprietary abuse-deterrent transdermal pain patch for pain relief; PTI-125, a small molecule drug candidate to treat Alzheimer's disease; and PTI-125DX, a blood-based diagnostic/biomarker to detect Alzheimer's disease. The company was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sciences, Inc. in March 2019. Cassava Sciences, Inc. was founded in 1998 and is based in Austin, Texas.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biology Pain Neuroscience Alzheimer's Disease Mental Health Biomarkers Psychiatric Diagnosis Psychiatry Nervous System Disorders Transdermal Abnormal Psychology

    Is SAVA a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 2 bullish, 1 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 23 Cassava Sciences, Inc. (SAVA)'s Technical Outlook is Bright After Key Golden Cross
    May 17 Peering Into Cassava Sciences's Recent Short Interest
    May 10 Cassava swings to Q1 profit as more patients finish simufilam phase 3 trials
    May 10 Cassava Sciences GAAP EPS of -$0.43 beats by $0.03
    May 10 Cassava Sciences Reports Q1 2024 Financial Results and Clinical Updates on Phase 3 Trials of Simufilam
    May 8 Cassava Sciences raises over $125M from warrant distribution
    May 8 Cassava Sciences Announces Over $125 Million Raised from Warrant Distribution
    May 1 Tomorrow is Last Day to Trade SAVAW Warrants on NASDAQ
    Apr 30 Stock Market Crash Warning: Don’t Get Caught Holding These 3 Biotech Stocks
    Apr 15 Redemption Date Announced for Warrants
    See more SAVA news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 32.1
    52 Week Low 12.3202
    Average Volume 830,622
    200-Day Moving Average 21.49
    50-Day Moving Average 21.62
    20-Day Moving Average 21.87
    10-Day Moving Average 22.06
    Average True Range 1.22
    RSI (14) 50.98
    ADX 10.86
    +DI 26.79
    -DI 17.64
    Chandelier Exit (Long, 3 ATRs) 20.47
    Chandelier Exit (Short, 3 ATRs) 23.58
    Upper Bollinger Bands 23.37
    Lower Bollinger Band 20.37
    Percent B (%b) 0.55
    BandWidth 13.70
    MACD Line 0.07
    MACD Signal Line 0.09
    MACD Histogram -0.0133
    Fundamentals Value
    Market Cap 930.48 Million
    Num Shares 42.2 Million
    EPS -2.29
    Price-to-Earnings (P/E) Ratio -9.62
    Price-to-Sales 0.00
    Price-to-Book 6.82
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 24.05
    Resistance 3 (R3) 24.12 23.51 23.72
    Resistance 2 (R2) 23.51 22.99 23.48 23.60
    Resistance 1 (R1) 22.77 22.68 22.46 22.70 23.49
    Pivot Point 22.16 22.16 22.01 22.13 22.16
    Support 1 (S1) 21.42 21.64 21.12 21.36 20.57
    Support 2 (S2) 20.81 21.33 20.78 20.46
    Support 3 (S3) 20.07 20.81 20.34
    Support 4 (S4) 20.01